Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
Jim Hoffman, Independent Consultant, shared a post on LinkedIn about recent articles, adding:
“ST-elevation myocardial infarction (STEMI) plus COVID-19 patients had nearly 4 times higher death rates than pre-pandemic controls (45% vs 11%), Even STEMI hospital survivors faced lasting risk; the mortality gradient didn’t stop at discharge.
Persistent One-Year Mortality Gradient After STEMI and COVID-19: Long-Term Outcomes From the NACMI
STEMI patients, like LC PASC patients, have exacerbated ‘NETosis dysregulation.’
Many STEMI patients have been shown to have lower but still elevated NETs even after Percutaneous Cornary Intervention.
Keeping their NETs lower could likely help prevent recurrence and also improve microvascular blood circulation and tissue perfusion.
NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?
Neutrophil extracellular traps (NETs) in patients with STEMI.
Association with percutaneous coronary intervention and antithrombotic treatments.
A NET removal therapy that should be trialed before, during, and post-treatment for STEMI/thrombectomy and for LC PASC where persistent NETs are also elevated, contributing to hypermicroclotting and risk for larger thrombotic complications.”
Title 1: Persistent One-Year Mortality Gradient After STEMI and COVID-19: Long-Term Outcomes From the NACMI Registry
Authors: Payam Dehghani, Chase J. Ellingson, BKina, Jyotpal Singh, Ellen Cravero, G.B. John Mancini, Larissa Stanberry, Mina Madan, Catherine P. Benziger, Nima Ghasemzadeh, Anna E. Bortnick, Rohan Kankaria, Cindy L. Grines, Keshav Nayak, Ehtisham Mahmud, Kevin R. Bainey, M. Chadi Alraies, Akshay Bagai, Rajan A.G. Patel, Shy Amlani, Brian C. Case, Ron Waksman, Jay S. Shavadia, Jay H. Stone, Deepak Acharya, Nosheen Javed, Rodrigo Bagur, Ross Garberich, Santiago Garcia, Timothy D. Henry
Title 2: NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?
Authors: Constance C.F.M.J. Baaten, Magdolna Nagy, Constance C.F.M.J. Baaten , Magdolna Nagy , Henri M.H. Spronk, Hugo Ten Cate , Bas L.J.H. Kietselaer
Title 3: Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments
Authors: Maria Ferré-Vallverdúa, Ana María Latorrec, María Paz Fusetb, Elena Sáncheza, Isabel Madridb, Francisco Tena, Juana Vallésc, María Teresa Santosc, Santiago Bonanadc, Antonio Moscardó
Title 4: Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID Patients
Authors: Alain R Thierry, Tom Usher, Cynthia Sanchez, Simone Turner, Chantelle Venter, Brice Pastor, Maxine Waters, Anel Thompson, Alexia Mirandola, Ekaterina Pisareva, Corinne Prevostel, Gert J Laubscher, Douglas B Kell, Etheresia Pretorius
Other posts featuring Jim Hoffman on Hemostasis Today.
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery